Radionetics Oncology Announces Initiation of Phase 1 Radiopharmaceutical Program Against a Novel Target for Adrenocortical Carcinoma
Clinical programs for novel targets for breast cancer and lung cancer planned
United States Brett Ewald Radionetics Oncology Inc University Of Michigan Rogel Cancer Center Radionetics Oncology Gary Hammer
Source: itnonline.com